| Online-Ressource |
Verfasst von: | Amelung, Stefanie [VerfasserIn]  |
| Meid, Andreas [VerfasserIn]  |
| Nafe, Michael [VerfasserIn]  |
| Thalheimer, Markus [VerfasserIn]  |
| Hoppe-Tichy, Torsten [VerfasserIn]  |
| Haefeli, Walter E. [VerfasserIn]  |
| Seidling, Hanna [VerfasserIn]  |
Titel: | Association of preventable adverse drug events with inpatients' length of stay |
Titelzusatz: | a propensity-matched cohort study |
Verf.angabe: | Stefanie Amelung, Andreas D. Meid, Michael Nafe, Markus Thalheimer, Torsten Hoppe-Tichy, Walter E. Haefeli, Hanna M. Seidling |
E-Jahr: | 2017 |
Jahr: | 05 September 2017 |
Umfang: | 9 S. |
Fussnoten: | Gesehen am 22.05.2018 |
Titel Quelle: | Enthalten in: The international journal of clinical practice |
Ort Quelle: | London : Hindawi Limited, 2004 |
Jahr Quelle: | 2017 |
Band/Heft Quelle: | 71(2017,10) Artikel-Nummer e12990, 9 Seiten |
ISSN Quelle: | 1742-1241 |
Abstract: | PURPOSE: Using clinical administrative data (CAD) of inpatients, we aimed to identify ICD-10 codes coding for potentially preventable inhospital adverse drug events (ADE) that affect the length of hospital stay (LOS) and thus patient well-being and cost. METHODS: We retrospectively assessed CAD of all inpatient stays in 2012 of a German university hospital. Predefined ICD-10 codes indicating ADE (ADE codes) were further specified based on expert ratings of the ADE mechanism and ADE preventability in clinical routine to particularly identify preventable inhospital ADE. In a propensity-matched cohort design, we compared patients with one or more ADE codes to control patients with regard to differences in LOS for three situations: all cases with an ADE code, cases with an inhospital ADE code, and cases with a preventable inhospital ADE code. RESULTS: Out of 54 032 cases analysed, in 8.3% (N=4 462) at least one ADE code was present. Nine of 128 evaluated ADE codes were rated as preventable in clinical routine, relating to 220 inpatients (4.9% of all identified inpatients with at least one ADE code and 0.4% of the entire cohort, respectively). Out of 48 072 evaluable inpatients for propensity score matching, 7 938 controls without ADE code and 4 006 cases with ADE code were selected. In all three settings, cases showed prolonged LOS vs controls (delta 1.13 d; 0.88 d and 1.88 d, respectively), significantly exceeding the maximum LOS as defined for each Diagnosis-Related Group. CONCLUSION: Inpatients with ADE codes referring to inhospital, potentially preventable ADE exceeded the maximum hospital stay fully reimbursed by insurance companies, indicating unnecessary long and costly inpatient stays. |
DOI: | doi:10.1111/ijcp.12990 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: http://dx.doi.org/10.1111/ijcp.12990 |
| DOI: https://doi.org/10.1111/ijcp.12990 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1575387905 |
Verknüpfungen: | → Zeitschrift |
Association of preventable adverse drug events with inpatients' length of stay / Amelung, Stefanie [VerfasserIn]; 05 September 2017 (Online-Ressource)